Show
Sort by
-
- Miscellaneous
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study (vol 72, pg 475, 2022)
-
- Journal Article
- A1
- open access
Pelophen B is a non-taxoid binding microtubule-stabilizing agent with promising preclinical anticancer properties
-
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
-
- Journal Article
- A1
- open access
Mapping bacterial extracellular vesicle research : insights, best practices and knowledge gaps
-
- Journal Article
- A1
- open access
Cancer‐associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer
-
- Conference Paper
- C3
- open access
BIMAP : breast cancer intra-operative margin assessment using PET-CT
-
- Journal Article
- A1
- open access
Exclusion of non-involved uterus from the target volume (EXIT-trial) : an individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery
-
- Journal Article
- A1
- open access
Zebrafish avatars : toward functional precision medicine in low-grade serous ovarian cancer
-
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer
-
- Journal Article
- A1
- open access
Identification and validation of extracellular vesicle reference genes for the normalization of RT‐qPCR data